Phyton Biotech LLC has bought the assets of Natural Pharmaceuticals Inc., a company that manufactures active ingredients for the oncology drug market.

Blue Cross and Blue Shield of North Carolina Inc. has named J. Bradley Wilson as its new president, effective immediately. He will remain chief operating officer, and Bob Greczyn continues as chief executive, the health insurer says.

Less than two years after its $25 million acquisition by I-Flow Corp., a Beaverton medical device company is about to get another new parent. (KMB) (IFLO)

Stephen Keith has left his executive post at embattled Panacea Pharmaceuticals Inc. to head the American College of Clinical Pharmacology.

The Food and Drug Administration has granted marketing approval for Berinert, a treatment developed by CSL Behring for acute abdominal or facial attacks in patients with hereditary angioedema.